An interventional study of Semi-quantitative pregnancy test in Menstrual Regulation, sponsored by Gynuity Health Projects. Completed at 11 sites in Pakistan. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-01-16.
Sponsored by Gynuity Health Projects · Not applicable, Interventional, and Health services research
The study seeks to test whether it is feasible and acceptable for both women and providers (in this context the Lady Health Visitor) to use the semi-quantitative pregnancy test (SQPT) as a tool for follow up after MR services. The study is planned at 11service delivery points (primary health clinics) in Punjab province where consenting women will be asked to take a baseline test at the clinic the morning they present for the MR procedure. Women will be asked to complete a second test at home the morning of their scheduled follow up visit and return to the clinic for follow-up care later that day. The results of the at home test will be compared to the baseline to determine the outcome of the MR. This is of particular importance because to-date no research has documented the accuracy of the test in detecting MR outcomes with misoprostol only regimens.
We hypothesize that women and providers will find the test easy and acceptable to use thereby improving follow up and simplifying MR service provision. In addition, the simple pictorial instructions will enable most women to use the test and interpret the results correctly on their own.
Gynuity Health Projects is the lead sponsor of 112 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Semi-quantitative urine pregnancy test (SQPT) (dBest One Step hCG Panel Test Kit)
Device: Semi-quantitative pregnancy test
Also known as: semi-quantitative urine pregnancy test (SQPT) (dBest One Step hCG Panel Test Kit)
Feasibility to determine successful completion of MR
1. The proportion of woman for whom Human Chorionic Gonadotropin (hCG) remains the same after MR 2. The proportion of woman for whom hCG remains increases after MR 3. The proportion of woman for whom hCG declines after MR 4. Any additional care received by women in each of the above groups (1-3) will also be described
Time frame: 2 weeks
Comprehension of pregnancy test
Proportion of women who correctly read and interpreted their results
Time frame: 2 weeks
Confidence in test
Proportion of women who were confident in using the test and would be willing to use it for follow up in the future
Time frame: 2 weeks
Selecting and receiving family planning method
Proportion of women selecting a method of family planning and receiving that method at their initial clinic visit.
Time frame: 2 weeks
This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gynuity Health Projects